Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02043691 · ClinicalTrials.gov registry record · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
A NA study of Aortic Dissection and Thoracoabdominal Aortic Aneurysm, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 410
- Enrollment target
- 1
- Study location
NCT02043691: Recruiting NA study of Aortic Dissection and Thoracoabdominal Aortic Aneurysm, sponsored by University of Alabama at Birmingham.
NCT02043691 is a NA study of Aortic Dissection and Thoracoabdominal Aortic Aneurysm that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 410 participants, below the 627-participant average among 11 other Aortic Dissection trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02043691, a NA study of Aortic Dissection and Thoracoabdominal Aortic Aneurysm, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 410 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center study to evaluate the safety and effectiveness of three investigational devices, the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and the Surgeon-Modified Endografts in the treatment of Juxtarenal, Suprarenal, Thoracoabdominal, and Aortic Arch pathologies involving the at least one brachiocephalic artery or visceral vessels. The three investigational devices offer an endovascular approach to treat complex aortic pathologies that cannot be treated with commercially available devices. This customized, endovascular approach has the potential to decrease hospital length of stay, pulmonary complications, and in-hospital mortality.
Conditions Studied
Interventions
- DEVICE Cook Custom Aortic Endograft
- DEVICE Zenith t-Branch Endovascular Graft
- DEVICE Surgeon-Modified Endograft
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2014-06 |
| Est. Completion | 2027-10 |
| Phase | NA |
What NCT02043691 shows while recruiting
NCT02043691 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 627-participant average among 11 other Aortic Dissection trials with a reported enrollment target (35% lower).
The record links to 6 conditions, with Aortic Dissection appearing as the primary indexed condition, and to 3 interventions - of which Cook Custom Aortic Endograft is the first listed.
NCT02043691 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT02043691 about?
NCT02043691 is a clinical study titled "Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies". This is a single-center study to evaluate the safety and effectiveness of three investigational devices, the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and the Surgeon-Modified Endografts in the treatment of Juxtarenal, Suprarenal, Thoracoabdominal, and Aortic Arch patholo...
What is the current status of trial NCT02043691?
This trial is currently recruiting. It is a NA study. The enrollment target is 410 participants. The study started on 2014-06. Estimated completion is 2027-10.
What conditions does trial NCT02043691 study?
This clinical trial studies the following conditions: Aortic Dissection, Thoracoabdominal Aortic Aneurysm, Aortic Arch Aneurysm, Juxtarenal Aortic Aneurysm, Penetrating Aortic Ulcer.
What interventions are being tested in trial NCT02043691?
The interventions under investigation include: Cook Custom Aortic Endograft (DEVICE), Zenith t-Branch Endovascular Graft (DEVICE), Surgeon-Modified Endograft (DEVICE).
Who is sponsoring clinical trial NCT02043691?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02043691 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Dissection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02043691's enrollment target sits among peer trials
410 3rd of 11 higher than 9 of 11 other Aortic Dissection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Dissection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
RECRUITING · NA
-
Feasibility of Endovascular Repair Of Ascending Aortic Pathologies
RECRUITING · NA
-
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
RECRUITING · NA
-
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
- NCT06064877 · 410 participants · Phase 3
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia